依帕列净-话题@MedSci

#依帕列净#

17篇内容 | 868人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1417296, encodeId=010b141e2967f, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=NEJM：依帕列净治疗心衰患者的心血管和肾脏结局, objectType=article, longId=201879, objectId=a1282018e9fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1282018e9fb, replyNumber=0, likeNumber=48, createdTime=2020-10-11, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1282018e9fb, moduleTitle=NEJM：依帕列净治疗心衰患者的心血管和肾脏结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1282018e9fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417295, encodeId=8748141e2954c, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=Circulation：依帕列净治疗心力衰竭：利尿和心肾效应, objectType=article, longId=200860, objectId=3403200860e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3403200860e5, replyNumber=0, likeNumber=32, createdTime=2020-09-19, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3403200860e5, moduleTitle=Circulation：依帕列净治疗心力衰竭：利尿和心肾效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3403200860e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417294, encodeId=5d98141e2949d, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=Blood：SGLT2抑制剂依帕列净成功纠正了糖原贮积症Ib的中性粒细胞减少及其功能障碍, objectType=article, longId=192947, objectId=49b619294e48, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49b619294e48, replyNumber=0, likeNumber=28, createdTime=2020-04-26, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49b619294e48, moduleTitle=Blood：SGLT2抑制剂依帕列净成功纠正了糖原贮积症Ib的中性粒细胞减少及其功能障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49b619294e48)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417293, encodeId=31c6141e29383, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=Circulation：依帕列净对2型糖尿病合并冠心病患者左心室的影响, objectType=article, longId=183385, objectId=0f86183385ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f86183385ef, replyNumber=0, likeNumber=48, createdTime=2019-11-23, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f86183385ef, moduleTitle=Circulation：依帕列净对2型糖尿病合并冠心病患者左心室的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f86183385ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417292, encodeId=01f1141e29221, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=Diabetes Care：依帕列净有效降低控制良好的2型糖尿病患者肝脏脂肪含量, objectType=article, longId=179794, objectId=2a6b1e979493, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a6b1e979493, replyNumber=0, likeNumber=42, createdTime=2019-09-22, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a6b1e979493, moduleTitle=Diabetes Care：依帕列净有效降低控制良好的2型糖尿病患者肝脏脂肪含量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a6b1e979493)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417291, encodeId=cb7e141e291e8, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=Circulation：依帕列净可降低T2D患者因心衰住院的风险, objectType=article, longId=175003, objectId=6a131e5003f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a131e5003f9, replyNumber=0, likeNumber=27, createdTime=2019-07-09, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a131e5003f9, moduleTitle=Circulation：依帕列净可降低T2D患者因心衰住院的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a131e5003f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417290, encodeId=1bae141e290c0, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=Circulation：依帕列净可有效用于糖尿病合并高血压的黑人患者, objectType=article, longId=165393, objectId=20e8165393c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20e8165393c1, replyNumber=0, likeNumber=32, createdTime=2019-05-06, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20e8165393c1, moduleTitle=Circulation：依帕列净可有效用于糖尿病合并高血压的黑人患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20e8165393c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417289, encodeId=6e30141e28972, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=Diabetic Med：钠-葡萄糖共转运蛋白-2抑制剂依帕列净在2型糖尿病年轻人中的药代动力学和药效学特征, objectType=article, longId=152526, objectId=ad2715252671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad2715252671, replyNumber=0, likeNumber=24, createdTime=2018-11-03, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad2715252671, moduleTitle=Diabetic Med：钠-葡萄糖共转运蛋白-2抑制剂依帕列净在2型糖尿病年轻人中的药代动力学和药效学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad2715252671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417288, encodeId=7bdf141e2888c, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=JASN：2型糖尿病患者服用依帕列净与肾功能下降的关系, objectType=article, longId=150987, objectId=8bde15098e49, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bde15098e49, replyNumber=0, likeNumber=40, createdTime=2018-10-15, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bde15098e49, moduleTitle=JASN：2型糖尿病患者服用依帕列净与肾功能下降的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bde15098e49)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417287, encodeId=c7a7141e2877e, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=JCEM：依帕列净可以改善2型糖尿病患者的β细胞的功能？, objectType=article, longId=126507, objectId=5f3412650ef7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f3412650ef7, replyNumber=0, likeNumber=46, createdTime=2018-01-16, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f3412650ef7, moduleTitle=JCEM：依帕列净可以改善2型糖尿病患者的β细胞的功能？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f3412650ef7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417286, encodeId=9932141e286e9, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=Diabetes：依帕列净与健康人和2型糖尿病患者的肾脏葡萄糖转运动力学分析!, objectType=article, longId=96847, objectId=6b6c9684e7a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b6c9684e7a, replyNumber=0, likeNumber=47, createdTime=2017-04-25, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b6c9684e7a, moduleTitle=Diabetes：依帕列净与健康人和2型糖尿病患者的肾脏葡萄糖转运动力学分析!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b6c9684e7a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417285, encodeId=d6fe141e285fc, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=Diabetes Care：依帕列净+二甲双胍联合治疗2型糖尿病, objectType=article, longId=77896, objectId=8445e78962a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8445e78962a, replyNumber=0, likeNumber=33, createdTime=2016-09-21, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8445e78962a, moduleTitle=Diabetes Care：依帕列净+二甲双胍联合治疗2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8445e78962a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417284, encodeId=2d99141e2845b, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=Diabetes Obes Metab：依帕列净可降低2型糖尿病患者血压, objectType=article, longId=61638, objectId=bf00616382f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf00616382f, replyNumber=0, likeNumber=37, createdTime=2016-01-06, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf00616382f, moduleTitle=Diabetes Obes Metab：依帕列净可降低2型糖尿病患者血压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf00616382f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417283, encodeId=09c8141e2835b, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=NEJM：依帕列净可降低2型糖尿病患者心血管事件和死亡的发生率, objectType=article, longId=59565, objectId=00635956590, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00635956590, replyNumber=0, likeNumber=33, createdTime=2015-11-28, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00635956590, moduleTitle=NEJM：依帕列净可降低2型糖尿病患者心血管事件和死亡的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00635956590)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417282, encodeId=5f13141e282d5, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=NEJM：依帕列净能下降2型糖尿病患者心血管事件和死亡率, objectType=article, longId=56624, objectId=bc7f56624d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc7f56624d2, replyNumber=0, likeNumber=36, createdTime=2015-09-28, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc7f56624d2, moduleTitle=NEJM：依帕列净能下降2型糖尿病患者心血管事件和死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc7f56624d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417281, encodeId=aaf3141e28122, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=Lancet Diab & Endo：依帕列净二线降糖不劣于格列美脲, objectType=article, longId=38002, objectId=88e53800233, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88e53800233, replyNumber=0, likeNumber=38, createdTime=2014-07-20, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88e53800233, moduleTitle=Lancet Diab & Endo：依帕列净二线降糖不劣于格列美脲, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88e53800233)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417280, encodeId=5229141e280ed, content=<a href='/topic/show?id=266826884bf' target=_blank style='color:#2F92EE;'>#依帕列净#</a>, objectTitle=Diabetes Obes Metab：依帕列净多重功效获新证据, objectType=article, longId=34376, objectId=03e8343e693, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03e8343e693, replyNumber=0, likeNumber=33, createdTime=2014-05-08, rootId=0, userName=DEXTER3140, userId=a0353248055, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03e8343e693, moduleTitle=Diabetes Obes Metab：依帕列净多重功效获新证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03e8343e693)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

依帕列净

2020-05-29

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

NEJM：依帕列净治疗心衰患者的心血管和肾脏结局

2020-10-11

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

Circulation：依帕列净治疗心力衰竭：利尿和心肾效应

2020-09-19

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

Blood：SGLT2抑制剂依帕列净成功纠正了糖原贮积症Ib的中性粒细胞减少及其功能障碍

2020-04-26

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

Circulation：依帕列净对2型糖尿病合并冠心病患者左心室的影响

2019-11-23

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

Diabetes Care：依帕列净有效降低控制良好的2型糖尿病患者肝脏脂肪含量

2019-09-22

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

Circulation：依帕列净可降低T2D患者因心衰住院的风险

2019-07-09

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

Circulation：依帕列净可有效用于糖尿病合并高血压的黑人患者

2019-05-06

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

Diabetic Med：钠-葡萄糖共转运蛋白-2抑制剂依帕列净在2型糖尿病年轻人中的药代动力学和药效学特征

2018-11-03

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

JASN：2型糖尿病患者服用依帕列净与肾功能下降的关系

2018-10-15

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

JCEM：依帕列净可以改善2型糖尿病患者的β细胞的功能？

2018-01-16

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

Diabetes：依帕列净与健康人和2型糖尿病患者的肾脏葡萄糖转运动力学分析!

2017-04-25

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

Diabetes Care：依帕列净+二甲双胍联合治疗2型糖尿病

2016-09-21

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

Diabetes Obes Metab：依帕列净可降低2型糖尿病患者血压

2016-01-06

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

NEJM：依帕列净可降低2型糖尿病患者心血管事件和死亡的发生率

2015-11-28

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

NEJM：依帕列净能下降2型糖尿病患者心血管事件和死亡率

2015-09-28

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

Lancet Diab & Endo：依帕列净二线降糖不劣于格列美脲

2014-07-20

DEXTER3140 (审核中...)

前往app查看评论内容

#依帕列净#

Diabetes Obes Metab：依帕列净多重功效获新证据

2014-05-08

科室
- - 订阅+
  - 更多科室
工具
服务